Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
URL: https://web.expasy.org/cellosaurus/CVCL_M294
Proper Citation: Coriell Cat# GM09653, RRID:CVCL_M294
Description: Cell line XP20MA is a Finite cell line with a species of origin Homo sapiens (Human)
Sex: Male
Disease: Xeroderma pigmentosum, complementation group C
Defining Citation: PMID:2054785, PMID:2175267, PMID:2570806, PMID:7165374
Category: Finite cell line
Expand AllWe found {{ ctrl2.mentions.all_count }} mentions in open access literature.
We have not found any literature mentions for this resource.
We are searching literature mentions for this resource.
Most recent articles:
{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})
A list of researchers who have used the resource and an author search tool
A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.
No rating or validation information has been found for XP20MA.
No alerts have been found for XP20MA.
Source: Cellosaurus
dkNET can assist you in preparing authentication plans for cell lines to comply with the NIH Submission Policy. The information can be used while planning your experiments or submitting grant applications. The authentication plan for the cell lines is based on the International Cell Line Authentication Committee (ICLAC)'s "Cell Line Checklist for Manuscripts and Grant Applications" and the example "Authentication of of Key Biological and/or Chemical Resources "(Bandrowski A). For best practices for authenticating cell lines, check our Authentication Reports services.